Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1954 3
1956 4
1957 2
1958 2
1960 2
1961 2
1962 1
1963 2
1964 2
1965 3
1966 2
1967 2
1968 4
1969 5
1970 5
1971 4
1972 5
1973 4
1974 1
1976 6
1977 4
1978 4
1979 7
1981 1
1985 2
1987 3
1988 2
1990 2
1991 2
1992 3
1994 2
1995 6
1996 2
1997 6
1998 2
1999 3
2000 6
2001 4
2002 5
2003 2
2004 6
2005 8
2006 4
2007 7
2008 6
2009 8
2010 6
2011 17
2012 14
2013 17
2014 7
2015 7
2016 6
2017 6
2018 5
2019 4
2020 1
2021 1
2022 1
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

247 results

Results by year

Filters applied: . Clear all
Page 1
Neurosarcoidosis.
Zajicek JP. Zajicek JP. Curr Opin Neurol. 2000 Jun;13(3):323-5. doi: 10.1097/00019052-200006000-00016. Curr Opin Neurol. 2000. PMID: 10871259 Review.
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
International Multiple Sclerosis Genetics Consortium (IMSGC); Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, Shah TS, Spencer C, Booth D, Goris A, Oturai A, Saarela J, Fontaine B, Hemmer B, Martin C, Zipp F, D'Alfonso S, Martinelli-Boneschi F, Taylor B, Harbo HF, Kockum I, Hillert J, Olsson T, Ban M, Oksenberg JR, Hintzen R, Barcellos LF; Wellcome Trust Case Control Consortium 2 (WTCCC2); International IBD Genetics Consortium (IIBDGC); Agliardi C, Alfredsson L, Alizadeh M, Anderson C, Andrews R, Søndergaard HB, Baker A, Band G, Baranzini SE, Barizzone N, Barrett J, Bellenguez C, Bergamaschi L, Bernardinelli L, Berthele A, Biberacher V, Binder TM, Blackburn H, Bomfim IL, Brambilla P, Broadley S, Brochet B, Brundin L, Buck D, Butzkueven H, Caillier SJ, Camu W, Carpentier W, Cavalla P, Celius EG, Coman I, Comi G, Corrado L, Cosemans L, Cournu-Rebeix I, Cree BA, Cusi D, Damotte V, Defer G, Delgado SR, Deloukas P, di Sapio A, Dilthey AT, Donnelly P, Dubois B, Duddy M, Edkins S, Elovaara I, Esposito F, Evangelou N, Fiddes B, Field J, Franke A, Freeman C, Frohlich IY, Galimberti D, Gieger C, Gourraud PA, Graetz C, Graham A, Grummel V, Guaschino C, Hadjixenofont… See abstract for full author list ➔ International Multiple Sclerosis Genetics Consortium (IMSGC), et al. Among authors: zajicek j. Nat Genet. 2013 Nov;45(11):1353-60. doi: 10.1038/ng.2770. Epub 2013 Sep 29. Nat Genet. 2013. PMID: 24076602 Free PMC article.
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2; Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, Potter SC, Goris A, Band G, Oturai AB, Strange A, Saarela J, Bellenguez C, Fontaine B, Gillman M, Hemmer B, Gwilliam R, Zipp F, Jayakumar A, Martin R, Leslie S, Hawkins S, Giannoulatou E, D'alfonso S, Blackburn H, Martinelli Boneschi F, Liddle J, Harbo HF, Perez ML, Spurkland A, Waller MJ, Mycko MP, Ricketts M, Comabella M, Hammond N, Kockum I, McCann OT, Ban M, Whittaker P, Kemppinen A, Weston P, Hawkins C, Widaa S, Zajicek J, Dronov S, Robertson N, Bumpstead SJ, Barcellos LF, Ravindrarajah R, Abraham R, Alfredsson L, Ardlie K, Aubin C, Baker A, Baker K, Baranzini SE, Bergamaschi L, Bergamaschi R, Bernstein A, Berthele A, Boggild M, Bradfield JP, Brassat D, Broadley SA, Buck D, Butzkueven H, Capra R, Carroll WM, Cavalla P, Celius EG, Cepok S, Chiavacci R, Clerget-Darpoux F, Clysters K, Comi G, Cossburn M, Cournu-Rebeix I, Cox MB, Cozen W, Cree BA, Cross AH, Cusi D, Daly MJ, Davis E, de Bakker PI, Debouverie M, D'hooghe MB, Dixon K, Dobosi … See abstract for full author list ➔ International Multiple Sclerosis Genetics Consortium, et al. Among authors: zajicek j. Nature. 2011 Aug 10;476(7359):214-9. doi: 10.1038/nature10251. Nature. 2011. PMID: 21833088 Free PMC article.
Multiple sclerosis.
Zajicek J. Zajicek J. Handb Clin Neurol. 2013;110:461-70. doi: 10.1016/B978-0-444-52901-5.00039-3. Handb Clin Neurol. 2013. PMID: 23312664 Review.
Meckel's Diverticulum With Perforation.
Ahmed M, Saeed R, Allawi A, Zajicek J. Ahmed M, et al. Among authors: zajicek j. Cureus. 2024 Aug 16;16(8):e67026. doi: 10.7759/cureus.67026. eCollection 2024 Aug. Cureus. 2024. PMID: 39280390 Free PMC article.
Thyrotoxic Hashimoto's encephalopathy.
Barker R, Zajicek J, Wilkinson I. Barker R, et al. Among authors: zajicek j. J Neurol Neurosurg Psychiatry. 1996 Feb;60(2):234. doi: 10.1136/jnnp.60.2.234. J Neurol Neurosurg Psychiatry. 1996. PMID: 8708668 Free PMC article. No abstract available.
Designing clinical trials in older people.
Carroll CB, Zajicek JP. Carroll CB, et al. Among authors: zajicek jp. Maturitas. 2011 Apr;68(4):337-41. doi: 10.1016/j.maturitas.2011.02.002. Epub 2011 Mar 3. Maturitas. 2011. PMID: 21376485 Review.
Cannabinoids on trial for multiple sclerosis.
Zajicek J. Zajicek J. Lancet Neurol. 2002 Jul;1(3):147. doi: 10.1016/s1474-4422(02)00068-6. Lancet Neurol. 2002. PMID: 12849481 Review. No abstract available.
The pathogenesis of demyelinating disease.
Scolding NJ, Zajicek JP, Wood N, Compston DA. Scolding NJ, et al. Among authors: zajicek jp. Prog Neurobiol. 1994 Jun;43(2):143-73. doi: 10.1016/0301-0082(94)90011-6. Prog Neurobiol. 1994. PMID: 7972853 Review. No abstract available.
Role of cannabinoids in multiple sclerosis.
Zajicek JP, Apostu VI. Zajicek JP, et al. CNS Drugs. 2011 Mar;25(3):187-201. doi: 10.2165/11539000-000000000-00000. CNS Drugs. 2011. PMID: 21323391 Review.
247 results